Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenR01NIDCDClinical trial: Optional / allowed

NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)

National Institute on Deafness and Other Communication Disorders (NIDCD) · NIH Institute/Center · RFA-DC-25-002

Source: Grants.gov · View original posting ↗

Award
Up to $500K
Deadline
Oct 12, 2027
Letter of intent
Mechanism
R01
Duration
Expected awards
Funding cycle
One-time
Open date
Dec 16, 2024
Total funding
$500K total
Clinical trial
Optional / allowed
Established investigatorGovernmentSmall businessHigher educationNonprofitForeign entities

Funding context

17%of applications funded

Based on FY2025 NIDCD R01 applications (96 of 571 applications awarded).

Payline: NIH discontinued percentile paylines for 2026 under its Unified Funding Strategy ↗ — scores are now weighed in context rather than against a fixed cutoff.

NIDCD R01, FY2025 — atypical NIH funding year (multi-year upfront funding / rescinded paylines); NIH reports FY2025 success rates as not comparable to prior years.

Aggregate historical data by institute, mechanism, and fiscal year — context for planning, not a prediction for this opportunity. Source ↗

Research areas

Biomarkers & diagnosticsTherapeutics & drug discoveryPrevention & risk factors

Auto-classified from the title and description (keyword-based) — may be imperfect.

Description

This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects which translate basic research findings into clinical tools for better human health. The scope of this FOA includes a range of activities to encourage translation of basic research findings which will impact the diagnosis, treatment and prevention of communication disorders. Connection to the clinical condition must be clearly established and the outcomes of the grant must have practical clinical impact.